Cargando…
Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
Serum samples were collected pre- and post-booster vaccination with Comirnaty in 626 participants (aged ≥ 50 years) who had received two Comirnaty doses < 30 days apart, two Comirnaty doses ≥ 30 days apart or two Vaxzevria doses ≥ 30 days apart. Irrespective of primary vaccine type or schedule, s...
Autores principales: | Ireland, Georgina, Whitaker, Heather, Ladhani, Shamez N, Baawuah, Frances, Subbarao, Sathyvani, Linley, Ezra, Warrener, Lenesha, O’Brien, Michelle, Whillock, Corinne, Martin, Oliver, Moss, Paul, Ramsay, Mary E, Amirthalingam, Gayatri, Brown, Kevin E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739342/ https://www.ncbi.nlm.nih.gov/pubmed/34991777 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.1.2101114 |
Ejemplares similares
-
Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
por: Subbarao, Sathyavani, et al.
Publicado: (2021) -
Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2022) -
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2021) -
Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
por: Vusirikala, Amoolya, et al.
Publicado: (2021) -
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
por: Westrop, Samantha J, et al.
Publicado: (2022)